Top Insights
US approves promising preventive HIV treatment
The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences lenacapavir, a twice-yearly injvirection, for preventing HIV infection in adults and adolescents at high risk of contracting the deadly virus. Lenacapavir proved nearly 100% effective at preventing HIV in large trials last year, raising new hope of interrupting transmission of the virus that infects 1.3 million people a year.
Related Articles
Outbreak of Israel-Iran war leaves China’s Mideast diplomacy at an impasse
Beijing has said it is prepared to act as peacemaker in the escalating...
What is Israel’s Iron Dome and why isn’t it invulnerable?
Israel’s Iron Dome is a highly advanced missile defence system designed to...
Trump sees disabling Iran nuclear site as necessary as he weighs strike
President Trump has been briefed on both the risks and the benefits...
Israel-Iran war: Internet blackout in Tehran
This Thursday, Tehran experienced no missile strikes, but a widespread communication blackout...
Leave a comment